🔗 Permalink

Inventor profile of:

Duncan Walker

City:

Boulder, Colorado

Country:

United States

Published Applications:

18

Last publication date:

2026-03-05

Top Assignees for applications by Duncan Walker

The entities that hold a legal rights for patent applications filed by inventor Walker Duncan:

Forma Therapeutics, Inc. 11 Watertown, MA United States
SUNESIS PHARMACEUTICALS, INC. 2 South San Francisco, CA United States
FORMA Therapeuetics, Inc. 1 Watertown, MA United States

Recent patent applications by Walker Duncan

Duncan Walker from Boulder, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-05

US20260060975A1

Human necessities

INHIBITING MUTANT IDH-1

#2 | 2026-01-15

US20260014138A1

Human necessities

INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)

#3 | 2026-01-01

US20260000664A1

Human necessities

TREATING PATIENTS HARBORING AN ISOCITRATE DEHYDROGENASE-1 (IDH-1) MUTATION

#4 | 2025-03-13

US20250082628A1

Human necessities

INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)

#5 | 2024-05-09

US20240148718A1

Human necessities

INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)

#6 | 2023-03-30

US20230101121A1

Human necessities

TREATING PATIENTS HARBORING AN ISOCITRATE DEHYDROGENASE-1 (IDH-1) MUTATION

#7 | 2023-03-02

US20230066088A1

Human necessities

Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)

#8 | 2021-08-12

US20210244727A1

Human necessities

Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)

#9 | 2021-07-01

US20210196701A1

Human necessities

INHIBITING MUTANT IDH-1

#10 | 2021-03-25

US20210085669A1

Human necessities

Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutation

#11 | 2020-09-24

US20200297717A1

Human necessities

Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)

#12 | 2020-04-09

US20200108060A1

Human necessities

Inhibiting mutant IDH-1

#13 | 2019-11-21

US20190350922A1

Human necessities

Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation

#14 | 2019-11-21

US20190350921A1

Human necessities

Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)

#15 | 2019-11-21

US20190350919A1

Human necessities

Inhibiting mutant IDH-1

#16 | 2018-04-12

US20180098975A1

Human necessities

METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF CANCER

#17 | 2014-07-24

US20140205680A1

Human necessities

METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID FOR TREATMENT OF CANCER

#18 | 2009-10-22

US20090263393A1

Human necessities

Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer

InventorID:

846141 ⎘